Are physicians neglecting the risk of heart failure in diabetic patients who are receiving sulfonylureas? Lessons from the TOSCA.IT trial

Comparative Safety of Sulfonylurea and Metformin Monotherapy on the Risk of Heart Failure: A Cohort Study

(2017) Christianne L. Roumie et al.   Journal of the American Heart Association

Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial

(2017) Olga Vaccaro et al.   Lancet Diabetes & Endocrinology

Effect of liraglutide, a glucagon-like peptide-1 analogue, on left ventricular function in stable chronic heart failure patients with and without diabetes (LIVE)-a multicentre, double-blind, randomised, placebo-controlled trial

(2016) Anders Jorsal et al.   EUROPEAN JOURNAL OF HEART FAILURE

Effects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction

(2016) Kenneth B. Margulies et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

(2015) Bernard Zinman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Glucose-lowering drugs or strategies and cardiovascular outcomes in patients with or at risk for type 2 diabetes: a meta-analysis of randomised controlled trials

(2015) Jacob A Udell et al.   Lancet Diabetes & Endocrinology

The risk of heart failure associated with the use of noninsulin blood glucose-lowering drugs: systematic review and meta-analysis of published observational studies

(2014) Cristina Varas-Lorenzo et al.   BMC Cardiovascular Disorders

Thiazolidinediones and Risk of Heart Failure in Patients with or at High Risk of Type 2 Diabetes Mellitus

(2011) Adrian V. Hernandez et al.   American Journal of Cardiovascular Drugs

Metformin treatment is associated with a low risk of mortality in diabetic patients with heart failure: a retrospective nationwide cohort study

(2010) C. Andersson et al.   DIABETOLOGIA

The Sulfonylurea Receptor, an Atypical ATP-Binding Cassette Protein, and Its Regulation of the K ATP Channel

(2008) Michael A. Burke et al.   CIRCULATION RESEARCH

The risk of heart failure in patients with type 2 diabetes treated with oral agent monotherapy

(2008) Finlay A. McAlister et al.   EUROPEAN JOURNAL OF HEART FAILURE